Genus plc
Genus plc Fundamental Analysis
Genus plc (GENSF) shows weak financial fundamentals with a PE ratio of 93.88, profit margin of 2.87%, and ROE of 3.89%. The company generates $0.7B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 39.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze GENSF's fundamental strength across five key dimensions:
Efficiency Score
WeakGENSF struggles to generate sufficient returns from assets.
Valuation Score
ModerateGENSF shows balanced valuation metrics.
Growth Score
ModerateGENSF shows steady but slowing expansion.
Financial Health Score
ExcellentGENSF maintains a strong and stable balance sheet.
Profitability Score
WeakGENSF struggles to sustain strong margins.
Key Financial Metrics
Is GENSF Expensive or Cheap?
P/E Ratio
GENSF trades at 93.88 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, GENSF's PEG of 0.09 indicates potential undervaluation.
Price to Book
The market values Genus plc at 3.81 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 17.16 times EBITDA. This signals the market has high growth expectations.
How Well Does GENSF Make Money?
Net Profit Margin
For every $100 in sales, Genus plc keeps $2.87 as profit after all expenses.
Operating Margin
Core operations generate 6.30 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $3.89 in profit for every $100 of shareholder equity.
ROA
Genus plc generates $2.15 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Genus plc generates limited operating cash flow of $67.71M, signaling weaker underlying cash strength.
Free Cash Flow
Genus plc produces free cash flow of $48.97M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.74 in free cash annually.
FCF Yield
GENSF converts 2.66% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
93.88
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.09
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.81
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.71
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.56
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.94
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.04
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How GENSF Stacks Against Its Sector Peers
| Metric | GENSF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 93.88 | 29.45 | Worse (Expensive) |
| ROE | 3.89% | 779.00% | Weak |
| Net Margin | 2.87% | -24936.00% (disorted) | Weak |
| Debt/Equity | 0.56 | 0.26 | Weak (High Leverage) |
| Current Ratio | 1.94 | 4.65 | Neutral |
| ROA | 2.15% | -19344.00% (disorted) | Weak |
GENSF outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Genus plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation